St. Patrick’s Day luck is coming earlier for the residents of Bay County, as the Bay County animal control announced a ...
MedPage Today on MSN
Another B-Cell Drug for Lupus Hits the Mark
Phase III results put obinutuzumab in line for approval ...
Good day, and thank you for standing by. Welcome to the Evaxion Business Update and Full Year 2025 Financial Results Webcast and Conference Call. [Operator Instructions]. Please be advised that ...
Bryce Young's former No. 1 wideout is a free agent. Here's why Carolina should go get him ...
Acute myeloid leukemia, often called AML, is one of the most aggressive forms of blood cancer. It develops in the bone marrow, the soft tissue inside bones where blood cells are made. In healthy ...
Everyday Health on MSN
If you’re new to weight training, start here
Starting weight training at home? Here’s the beginner-friendly equipment and expert tips you actually need to build strength safely.
But I'm not sure what the intermediate stages are.
It’s never been harder to become the scoring king at a top program.
The loud bang woke 16-year-old Mily with a start. Her mother, Randi Burns, fainted a month earlier on Christmas Eve, after compounding complications from a stomach bug and her small lymphocytic ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva® (obinutuzumab) in adults with systemic lupus ...
‘My scientific career is essentially over.’ A brain drain imperils Massachusetts’ biomedical future.
In a first-of-its-kind survey, the Globe asked hundreds of scientists about the impact of federal funding cuts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results